Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - axsym total t3 is a microparticle enzyme immunoassay (meia) for the quantitative determination of total circulating triiodothyronine (t3) in human serum or plasma on the axsym system. the axsym total t3 assay is used as an aid in the assessment of thyroid status.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - axsym ferritin is a microparticle enzyme immunoassay (meia) for the quantitative determination of ferritin in human serum or plasma.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the axsym β2-microglobulin assay is a microparticle enzyme immunoassay (meia) for the quantitative measurement of β2-microglobulin in human serum, plasma, or urine to be used as an aid in the management of patients with renal dysfunction or rheumatoid arthritis.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - the architect c systems and aeroset system ict (integrated chip technology) is used for the quantitation of sodium, potassium, and chloride in human serum, plasma, or urine.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect immunoassay analyzer system is a fully-automated immunoassay system allowing random and continuous access as well as priority and automated retest processing.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prism® hiv ag/ab combo is an in vitro chemiluminescent immunoassay (chlia) for the simultaneous qualitative detection of hiv p24 antigen and/or antibodies to human immunodeficiency virus type 1 and/or type 2 (hiv-1/hiv-2) in human serum or plasma. the abbott prism hiv ag/ab combo assay is intended to be used as a screening test for donated blood and plasma to prevent transmission of hiv-1/hiv-2 to recipients of blood and blood components, and as an aid in the diagnosis of hiv-1/hiv-2 infection. the abbott prism hiv ag/ab combo assay does not discriminate between hiv p24 antigen, hiv-1 antibody, or hiv-2 antibody reactivity.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect anti-hbe assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of antibody to hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect hbeag assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system. the architect hbeag assay can also be used for the quantitative determination of hbeag. refer to architect hbeag quantitative calibrators package insert (7p24-01) for instructions and further information.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect hbsag confirmatory v.1 assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma by means of specific antibody neutralization. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect free psa assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of free prostate specific antigen (psa) in human serum. it is intended to be used in conjunction with architect total psa assay in men aged 50 years or older with total psa values between 4 and 10 ng/ml and dre non-suspicious for cancer to determine the ratio of free psa to total psa. can be used as an aid in discriminating between prostate cancer and benign disease. use with abbott architect i2000 system and abbott architect i2000sr system.